We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.5B
AUM Growth
-$26.3M
Cap. Flow
-$36.9M
Cap. Flow %
-0.82%
Top 10 Hldgs %
8.67%
Holding
752
New
65
Increased
220
Reduced
377
Closed
83

Top Buys

Rank Stock Value
1
BOOT icon
Boot Barn
BOOT
+$17.2M
2
UPBD icon
Upbound Group
UPBD
+$10.9M
3
MRCY icon
Mercury Systems
MRCY
+$10.6M
4
KMPR icon
Kemper
KMPR
+$9.56M
5
ESAB icon
ESAB
ESAB
+$8.84M

Top Sells

Rank Stock Value
1
SF
Stifel
SF
+$19.5M
2
SHOO icon
Steven Madden
SHOO
+$17.6M
3
PHAT icon
Phathom Pharmaceuticals
PHAT
+$13.2M
4
B
Barnes Group Inc.
B
+$13.2M
5
WTFC icon
Wintrust Financial
WTFC
+$11M

Sector Composition

Rank Sector Weight
1 Financials 20.83%
2 Industrials 18.44%
3 Healthcare 17.49%
4 Technology 13.76%
5 Consumer Discretionary 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIGL icon
651
Rigel Pharmaceuticals
RIGL
$778M
$226K 0.01%
13,418
-81,131
-86% -$1.56M
IWC icon
652
iShares Micro-Cap ETF
IWC
$1.49B
$222K ﹤0.01%
+1,701
New +$221K
XEL icon
653
Xcel Energy
XEL
$48B
$216K ﹤0.01%
3,199
+9
+0.3% +$604
AXON
654
Axon Enterprise
AXON
$48.4B
$212K ﹤0.01%
+356
New +$194K
NAMS icon
655
NewAmsterdam Pharma
NAMS
$3.34B
$204K ﹤0.01%
7,945
-6,101
-43% -$130K
MGTX icon
656
MeiraGTx Holdings
MGTX
$1.21B
$204K ﹤0.01%
33,469
+6,203
+23% +$36.4K
MET icon
657
MetLife
MET
$61.7B
$202K ﹤0.01%
2,466
+8
+0.3% +$666
ARCT icon
658
Arcturus Therapeutics
ARCT
$200M
$186K ﹤0.01%
10,987
+2,036
+23% +$38.3K
IMNM icon
659
Immunome
IMNM
$2.91B
$154K ﹤0.01%
+14,521
New +$175K
NTLA icon
660
Intellia Therapeutics
NTLA
$1.68B
$150K ﹤0.01%
12,847
+2,381
+23% +$37.2K
KRON
661
DELISTED
Kronos Bio
KRON
$142K ﹤0.01%
149,251
+12,007
+9% +$11.3K
CMPS
662
Compass Pathways
CMPS
$1.78B
$128K ﹤0.01%
33,976
+6,297
+23% +$31.9K
SLND icon
663
Southland Holdings
SLND
$33M
$117K ﹤0.01%
36,042
-8,618
-19% -$28.7K
DSGN icon
664
Design Therapeutics
DSGN
$897M
$88K ﹤0.01%
+14,266
New +$82.6K
AAOI icon
665
Applied Optoelectronics
AAOI
$11.2B
– –
-263,655
Closed -$3.77M
AGX icon
666
Argan
AGX
$8.15B
– –
-12,824
Closed -$1.3M
ALXO icon
667
ALX Oncology
ALXO
$285M
– –
-74,679
Closed -$136K
AMAL icon
668
Amalgamated Financial
AMAL
$1.48B
– –
-115,334
Closed -$3.62M
ARRY icon
669
Array Technologies
ARRY
$819M
– –
-266,277
Closed -$1.76M
AVTR icon
670
Avantor
AVTR
$9.29B
– –
-120,684
Closed -$3.12M
BCYC
671
Bicycle Therapeutics
BCYC
$288M
– –
-261,067
Closed -$5.91M
BHVN icon
672
Biohaven
BHVN
$2.19B
– –
-8,484
Closed -$424K
BKSY icon
673
BlackSky Technology
BKSY
$1.17B
– –
-886,007
Closed -$4.2M
BMI icon
674
Badger Meter
BMI
$3.95B
– –
-7,863
Closed -$1.72M
BOOM icon
675
DMC Global
BOOM
$153M
– –
-25,386
Closed -$330K
25 26
27
28 29

Similar funds

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return

Kennedy Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Kennedy Capital Management held 752 positions worth $4.5B, down 0.58% from $4.53B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Kennedy Capital Management's Q4 2024 filing shows 65 new, 220 increased, 377 reduced and 83 closed positions. Its largest new stake was Boot Barn: 116,357 shares worth $17.7M. The largest sale was Stifel, an estimated $19.5M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

  • Kennedy Capital Management's largest Q4 2024 buy was Boot Barn: 116,357 shares worth $17.7M.
  • Kennedy Capital Management added most to Mercury Systems in Q4 2024, an estimated $10.6M increase.
  • Kennedy Capital Management's biggest Q4 2024 reduction was Stifel, cutting an estimated $19.5M.
  • Kennedy Capital Management fully exited Phathom Pharmaceuticals in Q4 2024, selling an estimated $13.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.7% of its $4.5B portfolio in Q4 2024.
  • Kennedy Capital Management opened 65 new positions and closed 83 in Q4 2024.
  • Kennedy Capital Management's portfolio value fell 0.58% quarter-over-quarter to $4.5B.

Based on Kennedy Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.